6160:HKG
BeOne Medicines AG
225,20 HKD
arrow_upward
+0,09%(+0,20) 1D
20. lis, 09:54:18 GMT+8 · HKD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 6160...
Otvori
221,00 HKD
Najviša
225,20 HKD
Najniža
221,00 HKD
Trž. kap.
355,98 mlr.
Prosj. kol.
3,06 mil.
Količina
526,00 tis.
P/E omjer
65,73
52-tjed. najviša
235,60 HKD
52-tjed. najniža
153,00 HKD
EPS
3,43 HKD
Dionice u optjecaju
1,43 mlr.
Broj djelatnika
12 tis.
Otvori
221,00 HKD
Najviša
225,20 HKD
Najniža
221,00 HKD
Trž. kap.
355,98 mlr.
Prosj. kol.
3,06 mil.
Količina
526,00 tis.
P/E omjer
65,73
52-tjed. najviša
235,60 HKD
52-tjed. najniža
153,00 HKD
EPS
3,43 HKD
Dionice u optjecaju
1,43 mlr.
Broj djelatnika
12 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
LIKA ONLINE
·
prije 13 sati
Na današnji dan dogodio se Crni ponedjeljak: Burze su se srušile, a stotine milijardi dolara vrijednosti nestale u nekoliko sati
CNBC
·
prije 59 minuta
CNBC Daily Open: Tech investors buy the dip — but debt remains a concern
Moomoo
·
prije 58 minuta
Morning Wrap | Singapore Export Forecast Raised to 25%; Nasdaq Rebounds as AI Tech Recovers
Action Forex
·
prije 44 minute
The S&P 500 Is on a Dangerous Path
Profil
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024, the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
BeOne Medicines AG – informacije
Glavni izvršni direktorJohn Vincent Oyler | John Vincent Oyler
Zaposlenici12 tis.
Osnovano28. lis 2010.
Sjedište-
Sektor-
Web-lokacijabeonemedicines.com